Clostridium difficile as a cause of acute diarrhea: A prospective study in a tertiary care center

Indian Journal of Gastroenterology

Volumn 32, Issue 3, 2013, Pages 179-183

  Ingle, Meghraj ^a   Deshmukh, Abhijit ^a   Desai, Devendra ^a   Abraham, Philip ^a   Joshi, Anand ^a   Gupta, Tarun ^a   Rodrigues, Camilla ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

Antibiotic associated diarrhea; Nosocomial infection; Risk factors

Indexed keywords

ANTIBIOTIC AGENT; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; METRONIDAZOLE; VANCOMYCIN;

ACUTE DIARRHEA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; COMMUNICABLE DISEASE; CONTROLLED STUDY; DRUG WITHDRAWAL; ENTERIC FEEDING; FECES ANALYSIS; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; INDIA; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PROSPECTIVE STUDY; SCHOOL CHILD; TERTIARY HEALTH CARE; TREATMENT DURATION; ACUTE DISEASE; COMPARATIVE STUDY; CROSS INFECTION; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; FOLLOW UP; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; RISK FACTOR; TERTIARY CARE CENTER; VERY ELDERLY; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DIARRHEA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIA; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84878284246     PISSN: 02548860     EISSN: 09750711     Source Type: Journal    
DOI: 10.1007/s12664-013-0303-8     Document Type: Article

References (36)

1. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia. N Engl J Med. 1978;298: 531-4.
2. Barbut F, Corthier G, Charpak Y, et al. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Arch Intern Med. 1996;156: 1449-54.
3. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med. 2002;346: 334-9.
4. Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother. 2008;62: 388-96.
5. Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ. 2008;179: 767-72.
6. Dhawan B, Chaudhry R, Sharma N. Incidence of Clostridium difficile infection: a prospective study in an Indian hospital. J Hosp Infect. 1999;43: 275-80.
7. Vaishnavi C, Kochhar R, Bhasin DK, Thapa BR, Singh K. Detection of Clostridium difficile toxin by an indigenously developed latex agglutination assay. Trop Gastroenterol. 1999;20: 33-5.
8. Vaishnavi C, Bhasin D, Kochhar R, Singh K. Clostridium difficile toxin and faecal lactoferrin assays in adult patients. Microbes Infect. 2000;2: 1827-30.
9. Vaishnavi C, Thapa BR, Thennarasu K, Singh K. Faecal lactoferrin assay as an adjunct to Clostridium difficile diarrhoea. Indian J Pathol Microbiol. 2002;45: 69-73.
10. Gogate A, De A, Nanivadekar R, et al. Diagnostic role of stool culture & toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children. Indian J Med Res. 2005;122: 518-24.
11. Dutta P, Mitra U, Rasaily R, et al. Prospective study of nosocomial enteric infections in a pediatric hospital. Calcutta Indian Pediatr. 1993;30: 187-94.
12. Niyogi SK, Bhattacharya SK, Dutta P, et al. Prevalence of Clostridium difficile in hospitalised patients with acute diarrhoea in Calcutta. J Diarrhoeal Dis Res. 1991;9: 16-9.
13. Chaudhry R, Joshy L, Kumar L, Dhawan B. Changing pattern of Clostridium difficile associated diarrhoea in a tertiary care hospital: a 5 year retrospective study. Indian J Med Res. 2008;127: 377-82.
14. Katyal R, Vaishnavi C, Singh K. Faecal excretion of brush border membrane enzymes in patients with Clostridium difficile diarrhoea. Indian J Med Microbiol. 2002;20: 178-82.
15. Gupta U, Yadav RN. Clostridium difficile in hospital patients. Indian J Med Res. 1985;82: 398-401.
16. Bhattacharya MK, Niyogi SK, Rasaily R, et al. Clinical manifestation of Clostridium difficile enteritis in Calcutta. J Assoc Physicians India. 1991;39: 683-4.
17. Ayyagiri ASP, Venkateshwarlu, Mehta S, Agarwal K. Prevalence of Clostridium difficile in pseudomembranous and antibiotic-associated Colitis in North India. J Diarrhoeal Dis Res. 1986;4: 157-60.
18. Ingle M, Deshmukh A, Desai D, et al. Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis. Indian J Gastroenterol. 2011;30: 89-93.
19. Bauer MP, Goorhuis A, Koster T, et al. Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage-two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea. Neth J Med. 2008;66: 207-11.
20. Manabe YC, Vinetz JM, Moore RD, Merz C, Charache P, Bartlett JG. Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med. 1995;123: 835-40.
21. Borek AP, Aird DZ, Carroll KC. Frequency of sample submission for optimal utilization of the cell culture cytotoxicity assay for detection of Clostridium difficile toxin. J Clin Microbiol. 2005;43: 2994-5.
22. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40: 1-15.
23. Manian FA, Meyer L. CDAD rates. Infect Control Hosp Epidemiol. 1995;16: 63-5.
24. Johnson S, Gerding DN. Clostridium difficile-associated diarrhea. Clin Infect Dis. 1998;26: 1027-34. quiz 35-6.
25. Rotimi VO, Mokaddas EM, Jamal WY, Verghese TL, El-Din K, Junaid TA. Hospital-acquired Clostridium difficile infection amongst ICU and burn patients in Kuwait. Med Princ Pract. 2002;11: 23-8.
26. Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41: 1254-60.
27. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007;45: 1543-9.
28. Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect. 2003;54: 243-5.
29. Asha NJ, Tompkins D, Wilcox MH. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol. 2006;44: 2785-91.
30. Rolfe RD. Role of volatile fatty acids in colonization resistance to Clostridium difficile. Infect Immun. 1984;45: 185-91.
31. Thurn J, Crossley K, Gerdts A, Maki M, Johnson J. Enteral hyperalimentation as a source of nosocomial infection. J Hosp Infect. 1990;15: 203-17.
32. Bliss DZ, Johnson S, Savik K, Clabots CR, Willard K, Gerding DN. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med. 1998;129: 1012-9.
33. May T, Mackie RI, Fahey GC Jr, Cremin JC, Garleb KA. Effect of fiber source on short-chain fatty acid production and on the growth and toxin production by Clostridium difficile. Scand J Gastroenterol. 1994;29: 916-22.
34. Wenisch C, Parschalk B, Hasenhundl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis. 1996;22: 813-8.
35. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45: 302-7.
36. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31: 431-55.